Clinical Trials in Phoenix

Showing 4081-4100 of 10,784 trials

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

NCT05074472

This study is a first-in-human, Phase 1, open label, multicenter, dose escalation study with expansion at the RP2D, to evaluate the safety, tolerability, and preliminary efficacy of ZB131 in patients with solid tumors where prevalence of CSP expression is high. Approximately 12 to 24 patients will be enrolled in the Dose Escalation Stage; the total number of patients will depend on the dose level at which the RP2D is defined. Patients who meet the eligibility criteria during Screening will enter the treatment period. ZB131 will be given via IV every week. Patients will be treated until disease progression or unacceptable toxicities occur.

Solid Tumor, AdultPancreatic Ductal; AdenocarcinomaOvarian Serous Adenocarcinoma+2 more

ZielBio, Inc.35 participantsStarted Jan 2022

Phoenix, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States +6 more locations

COMPLETEDNA< 1 mile

RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt

NCT04604015

This study is a multi-center, prospective, single-arm, non-significant risk (NSR) device study in which up to 150 evaluable subjects with suspicion of embolic stroke of undetermined source (ESUS) will be evaluated with NB-IS TCD and standard of care TTE to screen for right to left shunt (RLS) or patent foramen ovale (PFO). Additionally, up to 150 evaluable subjects will be evaluated with NB-IS TCD and standard of care TEE.

Embolic Stroke of Undetermined SourceTransient Ischemic AttackRight-To-Left Atrial Shunt+1 more

NovaSignal Corp.154 participantsStarted Oct 2020

Phoenix, Arizona, United States • Portland, Oregon, United States • Portland, Oregon, United States +4 more locations

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt

Find Trials by Condition in Phoenix

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip

Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)

EPI-743 for Mitochondrial Respiratory Chain Diseases

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

Tracking Renal Tumors After Cryoablation Evaluation

Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain

A Study of Mirikizumab in Participants With Plaque Psoriasis

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma

Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA

Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer